A 12-year study involving 1,221 married couples ages 65 or older (part of the Cache County (Utah) Memory Study) has revealed that husbands or wives who care for spouses with dementia are six times more likely to develop Alzheimer’s themselves than those whose spouses don't have it. The increased risk is of comparable size to having the ‘Alzheimer's gene’. The researchers speculate that the great stress of caregiving might be responsible for the increased dementia risk, emphasizing the need for greater caregiver support.
Looking after a spouse with dementia greatly increases your own risk of dementia
Reference
Norton, M. C., Smith, K. R., Østbye, T., Tschanz, J. T., Corcoran, C., Schwartz, S., … Welsh-Bohmer, K. A. (2010). Greater Risk of Dementia When Spouse Has Dementia? The Cache County Study. Journal of the American Geriatrics Society, 58(5), 895-900. Retrieved from http://dx.doi.org/10.1111/j.1532-5415.2010.02806.x
Related News
Cholesterol genes link risk of heart disease & Alzheimer’s
The APOE gene, the strongest genetic risk factor for Alzheimer’s disease, is known to be involved in cholesterol and lipid metabolism. Now the largest ever genetic study of Alzheimer’s disease, using DNA from more than 1.5 million people, has identified 90 points across the genome that were associated with an increased risk of both cardiovascular disease and Alzheimer’s disease.
Poor sleep drives Alzheimer’s progression
Poor sleep has been associated with the development of Alzheimer's disease, and this has been thought to be in part because the protein amyloid beta increases with sleep deprivation. A new study explains more.
Experiments with mice show that sleep deprivation also rapidly increases levels of the other key Alzheimer’s disease protein, tau tangles.
The work built on findings that tau is high in older people who sleep poorly, and that, when people are kept awake all night, their tau levels rise by about 50%.
Education & IQ linked to later cognitive decline & dementia
Americans with a college education live longer without dementia and Alzheimer's
Data from the large, long-running U.S. Health and Retirement Study found that healthy cognition characterized most of the people with at least a college education into their late 80s, while those who didn’t complete high school had good cognition up until their 70s.
If you flush when you drink alcohol, drinking may increase your risk of Alzheimer’s
Research using human cell cultures and mice suggests that those with an uncommon variation of the aldehyde dehydrogenase 2 gene (ALDH2) may be more at risk of Alzheimer's if they consume alcohol. This gene variation is associated with facial redness following alcohol consumption, reflecting reduced activity of an enzyme that protects against a toxin produced by alcohol consumption (acetaldehyde). Flushing, and inflammation, is a response to the toxin.
Diabetes duration and severity associated with brain atrophy
Submitted by Fiona McPherson
on
A study involving 614 patients with type 2 diabetes (mean age 62) has found that longer duration of diabetes was associated with more brain volume loss, particularly in the gray matter. Roughly, for every 10 years of diabetes, the brain was similar to that of a non-diabetic person who was two years older.
However, the study did not confirm any association of diabetes characteristics with small vessel ischemic disease.
http://www.eurekalert.org/pub_releases/2014-04/rson-dda042214.php
Shift away from glycemic control in diabetes treatment
Submitted by Fiona McPherson
on
It is now realized that the focus in treating diabetes shouldn’t be so much on controlling blood sugar. New medical guidelines point to the importance of the following interventions (in order of benefit):
- smoking cessation (most important)
- blood pressure control
- metformin drug therapy
- lipid reduction
- glycemic control (least important).
This isn’t to say that blood sugar isn’t important; but the others should be dealt with first.
Calcium supplements not associated with increased cardiovascular risk in women
Submitted by Fiona McPherson
on
Contradicting some earlier studies, new research using data from the very large and long-running Nurses' Health Study has found that calcium supplement intake was not associated with a higher risk of cardiovascular disease in women.
http://www.eurekalert.org/pub_releases/2014-05/bawh-csn050914.php
Low dietary fiber intake linked to increased cardiovascular risk
Submitted by Fiona McPherson
on
Data from the very large U.S. National Health and Nutrition Examination Survey (NHANES), involving 23,168 people, has found a significant association between low dietary fiber intake and risk of metabolic syndrome, cardiovascular inflammation, and obesity.
Dietary fiber intake was also consistently below recommended intake levels: 38g per day for men aged 19-50 years, 30g per day for men 50 and over, 25g for women aged 19-50 years, and 21g per day for women over 50. Mean dietary fiber intake was only 16.2g per day across all groups.
Why sleep is disrupted in Alzheimer's disease
Submitted by Fiona McPherson
on
A study involving genetically engineered fruit flies adds to our understanding of why sleep and bioclock disruptions are common in those with Alzheimer's disease. People with Alzheimer's often have poor biological rhythms — periods of sleep become shorter and more fragmented, resulting in periods of wakefulness at night and snoozing during the day. It has been thought that Alzheimer’s destroys the biological clock, but this new study indicates that the clock is still working — however, it’s being ignored by other parts of the brain.
Higher levels of copper in amyloid plaques associated with degree of neurodegeneration
Submitted by Fiona McPherson
on
Following on from the evidence that Alzheimer’s brains show higher levels of metals such as iron, copper, and zinc, a mouse study has found that amyloid plaques in Alzheimer’s-like brains with significant neurodegeneration have about 25% more copper than those with little neurodegeneration. This is consistent with a human study showing very high levels of copper in Alzheimer’s plaques.
Iron, though doubled in Alzheimer’s brains compared to controls, was not significantly different as a function of neurodegeneration, and zinc showed very little difference.